In this study, through database analysis and clinical tissue studies, we demonstrated that the expression of CTHRC1 was significantly associated with the BRAF(V600E) mutation in colon cancer, thyroid cancer, and melanoma. This evidence concerns the gene BRAF and thyroid cancer.